IMRX

Immuneering CorpCIK 1790340 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for IMRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for IMRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Gengos Andrew	Chief Financial Officer	1	$0	$0	2026-07-16
Zeskind Benjamin J.	President and CEO	25	$254.6K	$0	2026-06-23
Hall Brett Matthew	Chief Scientific Officer	19	$128.8K	$0	2026-06-15
Feinberg Peter	Director	33	$5.20M	$0	2026-06-11
KEATING LAURIE	Director	10	$140.0K	$0	2026-06-11
HAUSMAN DIANA	Director	8	$19.9K	$0	2026-06-11
Schall Thomas J.	Director	8	$232.7K	$0	2026-06-11
CARPENTER ROBERT J	Director	9	$4.88M	$0	2026-06-11
Neufeld Leah R	CHIEF PEOPLE OFFICER	18	$29.5K	$0	2026-03-13
Brakewood Harold Eugene	Chief Business Officer	11	$39.8K	$0	2026-02-03
Morales Mallory	VICE PRESIDENT, FINANCE	24	$5.9K	$0	2026-02-03
Bookman Michael	General Counsel and Secretary	18	$32.9K	$0	2026-02-03
Matushansky Igor	Chief Medical Officer	2	$0	$0	2026-02-03
BERMAN ANN E	Director	10	$214.4K	$0	2025-06-13
Cormorant Private Healthcare Fund III LP	10% Owner	8	$0	$1.16M	2024-04-01
Cormorant Global Healthcare Master Fund, LP	10% Owner	5	$0	$2.75M	2024-03-15
Barrett Scott	Chief Medical Officer	7	$16.7K	$0	2023-02-15
Amin Biren	CFO, Treasurer	5	$67.0K	$0	2022-05-12
Cormorant Asset Management, LP	Other	3	$8.25M	$0	2021-08-03

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Gengos Andrew	Chief Financial Officer	A Award deriv	2026-07-16	2026-07-17	650,000	—	$0	650,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2026-06-23	2026-06-24	2,400	$4.56	$10.9K	2,315,252	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2026-06-15	2026-06-16	6,035	$4.15	$25.0K	382,531	SEC↗
Feinberg Peter	Director	A Award deriv	2026-06-11	2026-06-11	33,350	—	$0	33,350	SEC↗
KEATING LAURIE	Director	A Award deriv	2026-06-11	2026-06-11	33,350	—	$0	33,350	SEC↗
CARPENTER ROBERT J	Director	A Award deriv	2026-06-11	2026-06-11	33,350	—	$0	33,350	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2026-06-11	2026-06-11	33,350	—	$0	33,350	SEC↗
Schall Thomas J.	Director	A Award deriv	2026-06-11	2026-06-11	33,350	—	$0	33,350	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award	2026-03-13	2026-03-17	3,628	$4.29	$15.6K	29,598	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2026-02-03	2026-02-05	688,000	—	$0	688,000	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2026-02-03	2026-02-05	140,000	—	$0	140,000	SEC↗
Morales Mallory	SVP Finance, CAO	A Award deriv	2026-02-03	2026-02-05	140,000	—	$0	140,000	SEC↗
Matushansky Igor	Chief Medical Officer	A Award deriv	2026-02-03	2026-02-05	140,000	—	$0	140,000	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award deriv	2026-02-03	2026-02-05	344,000	—	$0	344,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2026-02-03	2026-02-05	140,000	—	$0	140,000	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2026-02-03	2026-02-05	176,000	—	$0	176,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	P Buy	2026-01-16	2026-01-21	5,250	$4.76	$25.0K	11,050	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2026-01-15	2026-01-16	2,298	$4.57	$10.5K	376,496	SEC↗
Schall Thomas J.	Director	P Buy	2026-01-15	2026-01-20	21,645	$4.67	$101.1K	74,530	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	P Buy	2026-01-13	2026-01-15	2,626	$4.15	$10.9K	25,970	SEC↗
Feinberg Peter	Director	P Buy	2026-01-12	2026-01-14	20,000	$4.35	$87.0K	135,441	SEC↗
Feinberg Peter	Director	A Award deriv	2026-01-01	2026-01-02	7,888	—	$0	7,888	SEC↗
KEATING LAURIE	Director	A Award deriv	2026-01-01	2026-01-02	7,888	—	$0	7,888	SEC↗
Feinberg Peter	Director	P Buy	2025-10-03	2025-10-07	7,500	$6.67	$50.0K	156,766	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	P Buy	2025-10-01	2025-10-02	1,020	$6.83	$7.0K	4,870	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	P Buy	2025-10-01	2025-10-02	800	$6.38	$5.1K	23,344	SEC↗
Morales Mallory	Chief Accounting Officer	P Buy	2025-10-01	2025-10-02	300	$6.39	$1.9K	27,533	SEC↗
Feinberg Peter	Director	P Buy	2025-09-30	2025-10-01	7,500	$7.03	$52.7K	149,266	SEC↗
Feinberg Peter	Director	P Buy	2025-09-29	2025-09-30	5,000	$7.18	$35.9K	141,766	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award	2025-09-15	2025-09-17	14,880	$1.43	$21.3K	374,198	SEC↗
Morales Mallory	Chief Accounting Officer	A Award	2025-09-15	2025-09-17	14,497	$1.43	$20.7K	27,233	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award	2025-09-15	2025-09-17	11,815	$1.43	$16.9K	22,544	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2025-07-02	2025-07-03	7,015	$3.53	$24.8K	2,312,852	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	P Buy	2025-07-02	2025-07-07	700	$3.57	$2.5K	10,729	SEC↗
HAUSMAN DIANA	Director	P Buy	2025-07-02	2025-07-07	3,000	$3.62	$10.9K	3,000	SEC↗
HAUSMAN DIANA	Director	P Buy	2025-07-02	2025-07-07	2,500	$3.60	$9.0K	2,500	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2025-07-01	2025-07-03	2,985	$3.38	$10.1K	2,305,837	SEC↗
Schall Thomas J.	Director	P Buy	2025-06-27	2025-06-30	9,500	$3.66	$34.8K	52,885	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2025-06-23	2025-06-24	6,007	$2.43	$14.6K	359,318	SEC↗
Brakewood Harold Eugene	Chief Business Officer	P Buy	2025-06-20	2025-06-24	1,900	$2.53	$4.8K	5,800	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2025-06-20	2025-06-24	7,415	$2.70	$20.0K	353,311	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2025-06-18	2025-06-20	21,000	$2.39	$50.2K	2,302,852	SEC↗
Feinberg Peter	Director	P Buy	2025-06-18	2025-06-23	25,000	$2.53	$63.2K	136,766	SEC↗
Schall Thomas J.	Director	P Buy	2025-06-17	2025-06-18	40,485	$2.21	$89.5K	43,385	SEC↗
BERMAN ANN E	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
CARPENTER ROBERT J	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
Feinberg Peter	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
KEATING LAURIE	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
Schall Thomas J.	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2025-06-13	2025-06-16	33,350	—	$0	33,350	SEC↗
Matushansky Igor	Chief Medical Officer	A Award deriv	2025-03-21	2025-03-24	118,000	—	$0	118,000	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2025-02-05	2025-02-07	110,000	—	$0	110,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2025-02-05	2025-02-07	480,000	—	$0	480,000	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-02-05	2025-02-07	240,000	—	$0	240,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2025-02-05	2025-02-07	100,000	—	$0	100,000	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2025-02-05	2025-02-07	110,000	—	$0	110,000	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2025-02-05	2025-02-07	110,000	—	$0	110,000	SEC↗
KEATING LAURIE	Director	A Award deriv	2025-01-01	2025-01-02	23,485	—	$0	23,485	SEC↗
Feinberg Peter	Director	A Award deriv	2025-01-01	2025-01-02	23,485	—	$0	23,485	SEC↗
BERMAN ANN E	Director	A Award deriv	2025-01-01	2025-01-02	17,614	—	$0	17,614	SEC↗
BERMAN ANN E	Director	A Award deriv	2025-01-01	2025-01-02	23,485	—	$0	23,485	SEC↗
Morales Mallory	Chief Accounting Officer	A Award	2024-09-15	2024-09-17	4,458	$1.62	$7.2K	12,736	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2024-06-12	2024-06-13	33,350	—	$0	33,350	SEC↗
BERMAN ANN E	Director	A Award deriv	2024-06-12	2024-06-13	33,350	—	$0	33,350	SEC↗
Feinberg Peter	Director	A Award deriv	2024-06-12	2024-06-13	33,350	—	$0	33,350	SEC↗
CARPENTER ROBERT J	Director	A Award deriv	2024-06-12	2024-06-13	33,350	—	$0	33,350	SEC↗
KEATING LAURIE	Director	A Award deriv	2024-06-12	2024-06-13	33,350	—	$0	33,350	SEC↗
Schall Thomas J.	Director	A Award deriv	2024-06-12	2024-06-13	8,588	—	$0	8,588	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2024-05-21	2024-05-23	88,600	—	$0	88,600	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2024-05-21	2024-05-23	60,500	—	$0	60,500	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	D To issuer deriv	2024-05-21	2024-05-23	60,500	—	$0	0	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2024-05-21	2024-05-23	105,000	—	$0	105,000	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	D To issuer deriv	2024-05-21	2024-05-23	105,000	—	$0	0	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	D To issuer deriv	2024-05-21	2024-05-23	88,600	—	$0	0	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2024-05-21	2024-05-23	165,000	—	$0	165,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2024-05-21	2024-05-23	60,500	—	$0	60,500	SEC↗
Brakewood Harold Eugene	Chief Business Officer	D To issuer deriv	2024-05-21	2024-05-23	165,000	—	$0	0	SEC↗
Brakewood Harold Eugene	Chief Business Officer	D To issuer deriv	2024-05-21	2024-05-23	60,500	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	5,000	—	$0	5,000	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	72,000	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	60,500	—	$0	60,500	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	60,500	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	15,000	—	$0	15,000	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	15,000	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	72,000	—	$0	72,000	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	5,000	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	23,850	—	$0	23,850	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	23,850	—	$0	0	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-05-21	2024-05-23	10,000	—	$0	10,000	SEC↗
Morales Mallory	Chief Accounting Officer	D To issuer deriv	2024-05-21	2024-05-23	10,000	—	$0	0	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2024-05-21	2024-05-23	93,000	—	$0	93,000	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	D To issuer deriv	2024-05-21	2024-05-23	93,000	—	$0	0	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2024-05-21	2024-05-23	143,000	—	$0	143,000	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	D To issuer deriv	2024-05-21	2024-05-23	143,000	—	$0	0	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2024-05-21	2024-05-23	47,300	—	$0	47,300	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	D To issuer deriv	2024-05-21	2024-05-23	47,300	—	$0	0	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2024-05-21	2024-05-23	101,116	—	$0	101,116	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	D To issuer deriv	2024-05-21	2024-05-23	101,116	—	$0	0	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	100	$3.05	$305	3,294,773	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	600	$3.03	$1.8K	3,294,173	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	100	$3.07	$307	3,295,173	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	300	$3.07	$921	3,294,873	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	398,600	$2.90	$1.16M	2,895,273	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	10	$3.01	$30	3,294,163	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	10	$2.98	$30	3,294,153	SEC↗
Cormorant Private Healthcare F	10% Owner	S Sale	2024-04-01	2024-04-03	280	$2.97	$832	3,293,873	SEC↗
Morales Mallory	Chief Accounting Officer	P Buy	2024-03-22	2024-03-25	393	$2.55	$1.0K	8,278	SEC↗
Brakewood Harold Eugene	Chief Business Officer	P Buy	2024-03-22	2024-03-25	3,900	$2.57	$10.0K	3,900	SEC↗
Feinberg Peter	Director	P Buy	2024-03-22	2024-03-25	25,000	$2.55	$63.7K	111,766	SEC↗
Schall Thomas J.	Director	P Buy	2024-03-22	2024-03-25	2,900	$2.55	$7.4K	2,900	SEC↗
Morales Mallory	Chief Accounting Officer	P Buy	2024-03-21	2024-03-25	1,107	$2.72	$3.0K	7,885	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2024-03-20	2024-03-21	7,000	$2.86	$20.0K	345,896	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	P Buy	2024-03-20	2024-03-21	3,818	$2.88	$11.0K	10,029	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2024-03-19	2024-03-19	20,000	$2.77	$55.4K	2,281,852	SEC↗
Feinberg Peter	Director	P Buy	2024-03-19	2024-03-19	25,000	$2.56	$64.0K	86,766	SEC↗
Feinberg Peter	Director	P Buy	2024-03-18	2024-03-19	45,024	$2.31	$104.0K	56,790	SEC↗
Feinberg Peter	Director	P Buy	2024-03-18	2024-03-19	4,976	$3.05	$15.2K	61,766	SEC↗
BERMAN ANN E	Director	P Buy	2024-03-18	2024-03-19	57,965	$2.13	$123.5K	67,465	SEC↗
Cormorant Global Healthcare Ma	10% Owner	S Sale	2024-03-15	2024-03-18	400,000	$2.14	$856.0K	3,295,273	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award	2024-03-15	2024-03-19	1,448	$1.62	$2.3K	3,850	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award	2024-03-15	2024-03-21	6,211	$1.62	$10.1K	338,896	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award	2024-03-15	2024-03-21	6,211	$1.62	$10.1K	6,211	SEC↗
Morales Mallory	Chief Accounting Officer	A Award	2024-03-15	2024-03-25	4,344	$1.62	$7.0K	6,778	SEC↗
Cormorant Global Healthcare Ma	10% Owner	S Sale	2024-03-14	2024-03-18	345,266	$3.24	$1.12M	3,859,098	SEC↗
Cormorant Global Healthcare Ma	10% Owner	S Sale	2024-03-14	2024-03-18	98,570	$4.25	$418.9K	3,760,528	SEC↗
Cormorant Global Healthcare Ma	10% Owner	S Sale	2024-03-14	2024-03-18	54,215	$5.37	$291.1K	3,706,313	SEC↗
Cormorant Global Healthcare Ma	10% Owner	S Sale	2024-03-14	2024-03-18	11,040	$5.97	$65.9K	3,695,273	SEC↗
Schall Thomas J.	Director	A Award deriv	2024-03-11	2024-03-12	35,000	—	$0	35,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2024-02-08	2024-02-09	16,414	—	$0	16,414	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2024-02-08	2024-02-09	244,286	—	$0	244,286	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-02-08	2024-02-09	130,900	—	$0	130,900	SEC↗
Bookman Michael	CHIEF LEGAL OFFICER, SECRETA	A Award deriv	2024-02-08	2024-02-09	93,000	—	$0	93,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2024-02-08	2024-02-09	60,500	—	$0	60,500	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2024-02-08	2024-02-09	60,500	—	$0	60,500	SEC↗
Morales Mallory	Chief Accounting Officer	A Award deriv	2024-02-08	2024-02-09	60,500	—	$0	60,500	SEC↗
Feinberg Peter	Director	A Award deriv	2024-01-01	2024-01-02	6,879	—	$0	6,879	SEC↗
KEATING LAURIE	Director	A Award deriv	2024-01-01	2024-01-02	6,879	—	$0	6,879	SEC↗
BERMAN ANN E	Director	A Award deriv	2023-06-14	2023-06-15	17,500	—	$0	17,500	SEC↗
CARPENTER ROBERT J	Director	A Award deriv	2023-06-14	2023-06-15	17,500	—	$0	17,500	SEC↗
Feinberg Peter	Director	A Award deriv	2023-06-14	2023-06-15	17,500	—	$0	17,500	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2023-06-14	2023-06-15	17,500	—	$0	17,500	SEC↗
KEATING LAURIE	Director	A Award deriv	2023-06-14	2023-06-15	17,500	—	$0	17,500	SEC↗
Morales Mallory	VICE PRESIDENT, FINANCE	A Award deriv	2023-06-13	2023-06-14	15,000	—	$0	15,000	SEC↗
Brakewood Harold Eugene	Chief Business Officer	A Award deriv	2023-03-31	2023-04-03	165,000	—	$0	165,000	SEC↗
Bookman Michael	GENERAL COUNSEL AND SECRETAR	A Award deriv	2023-02-15	2023-02-17	143,000	—	$0	143,000	SEC↗
Barrett Scott	CHIEF MEDICAL OFFICER	A Award deriv	2023-02-15	2023-02-17	110,000	—	$0	110,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2023-02-15	2023-02-17	21,756	—	$0	374,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2023-02-15	2023-02-17	352,244	—	$0	352,244	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award deriv	2023-02-15	2023-02-17	187,000	—	$0	187,000	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2023-02-15	2023-02-17	105,000	—	$0	105,000	SEC↗
Morales Mallory	VICE PRESIDENT, FINANCE	A Award deriv	2023-02-15	2023-02-17	72,000	—	$0	72,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise deriv	2022-12-22	2022-12-27	2,500	—	$0	203,500	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise	2022-12-22	2022-12-27	2,500	$3.01	$7.5K	2,261,852	SEC↗
Neufeld Leah R	CHIEF PEOPLE OFFICER	A Award deriv	2022-10-31	2022-11-02	88,600	—	$0	88,600	SEC↗
Morales Mallory	VICE PRESIDENT, FINANCE	A Award deriv	2022-08-11	2022-08-12	10,000	—	$0	10,000	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2022-06-21	2022-06-23	6,185	—	$0	6,185	SEC↗
KEATING LAURIE	Director	A Award deriv	2022-06-21	2022-06-23	14,200	—	$0	14,200	SEC↗
CARPENTER ROBERT J	Director	A Award deriv	2022-06-21	2022-06-23	14,200	—	$0	14,200	SEC↗
Feinberg Peter	Director	A Award deriv	2022-06-21	2022-06-23	14,200	—	$0	14,200	SEC↗
BERMAN ANN E	Director	A Award deriv	2022-06-21	2022-06-23	14,200	—	$0	14,200	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2022-05-25	2022-05-27	2,551	$3.92	$10.0K	332,685	SEC↗
Bookman Michael	GENERAL COUNSEL AND SECRETAR	P Buy	2022-05-17	2022-05-18	1,000	$4.88	$4.9K	2,402	SEC↗
KEATING LAURIE	Director	P Buy	2022-05-16	2022-05-17	7,000	$5.00	$35.0K	14,000	SEC↗
Amin Biren	CFO, TREASURER	P Buy	2022-05-12	2022-05-12	1,000	$4.42	$4.4K	7,898	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise deriv	2022-04-12	2022-04-14	2,000	—	$0	206,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise	2022-04-12	2022-04-14	2,000	$3.01	$6.0K	2,259,352	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	P Buy	2022-03-23	2022-03-23	1,050	$7.91	$8.3K	330,134	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2022-03-23	2022-03-24	3,000	$8.02	$24.1K	2,257,352	SEC↗
Barrett Scott	CHIEF MEDICAL OFFICER	P Buy	2022-03-22	2022-03-22	900	$7.49	$6.7K	7,563	SEC↗
BERMAN ANN E	Director	P Buy	2022-03-15	2022-03-15	6,000	$6.40	$38.4K	9,500	SEC↗
Feinberg Peter	Director	P Buy	2022-03-15	2022-03-16	6,667	$6.75	$45.0K	11,766	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise deriv	2022-02-28	2022-03-01	2,000	—	$0	208,000	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	M Exercise	2022-02-28	2022-03-01	2,000	$3.01	$6.0K	2,254,352	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2022-02-10	2022-02-14	156,485	—	$0	156,485	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	A Award deriv	2022-02-10	2022-02-14	45,615	—	$0	202,100	SEC↗
Bookman Michael	GENERAL COUNSEL AND SECRETAR	A Award deriv	2022-02-10	2022-02-14	47,300	—	$0	47,300	SEC↗
Barrett Scott	CHIEF MEDICAL OFFICER	A Award deriv	2022-02-10	2022-02-14	71,850	—	$0	71,850	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award deriv	2022-02-10	2022-02-14	83,100	—	$0	83,100	SEC↗
Amin Biren	CFO, TREASURER	A Award deriv	2022-02-10	2022-02-14	70,050	—	$0	70,050	SEC↗
HAUSMAN DIANA	Director	A Award deriv	2022-01-14	2022-01-18	25,200	$13.00	$327.6K	25,200	SEC↗
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	A Award	2021-12-22	2021-12-22	322,691	—	$0	329,084	SEC↗
Feinberg Peter	Director	P Buy	2021-09-20	2021-09-21	4,750	$24.45	$116.1K	5,099	SEC↗
Zeskind Benjamin J.	PRESIDENT AND CEO	P Buy	2021-09-13	2021-09-14	2,083	$22.87	$47.6K	2,602,352	SEC↗
Feinberg Peter	Director	P Buy	2021-09-13	2021-09-15	5,750	$21.51	$123.7K	392,242	SEC↗
Feinberg Peter	Director	P Buy	2021-09-13	2021-09-15	349	$21.25	$7.4K	349	SEC↗
Amin Biren	CFO, Treasurer	C Conversion deriv	2021-08-03	2021-08-04	2,723	—	$0	0	SEC↗
Barrett Scott	Chief Medical Officer	C Conversion deriv	2021-08-03	2021-08-04	3,273	—	$0	0	SEC↗
Barrett Scott	Chief Medical Officer	C Conversion deriv	2021-08-03	2021-08-04	2,723	—	$0	0	SEC↗
CARPENTER ROBERT J	Director	C Conversion deriv	2021-08-03	2021-08-04	122,588	—	$0	0	SEC↗
CARPENTER ROBERT J	Director	C Conversion deriv	2021-08-03	2021-08-04	94,585	—	$0	0	SEC↗
Hall Brett Matthew	Chief Scientific Officer	C Conversion deriv	2021-08-03	2021-08-04	3,404	—	$0	0	SEC↗
Hall Brett Matthew	Chief Scientific Officer	C Conversion deriv	2021-08-03	2021-08-04	1,636	—	$0	0	SEC↗
Zeskind Benjamin J.	President and CEO	C Conversion deriv	2021-08-03	2021-08-04	8,171	—	$0	0	SEC↗
Zeskind Benjamin J.	President and CEO	C Conversion deriv	2021-08-03	2021-08-04	40,928	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	30,646	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	30,646	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	102,926	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	92,509	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	51,462	—	$0	0	SEC↗
Feinberg Peter	Director	C Conversion deriv	2021-08-03	2021-08-04	30,646	—	$0	0	SEC↗
Cormorant Asset Management, LP	Other	C Conversion deriv	2021-08-03	2021-08-05	1,702,628	—	$0	0	SEC↗
Amin Biren	CFO, Treasurer	C Conversion	2021-08-03	2021-08-04	2,723	—	$0	2,723	SEC↗
Amin Biren	CFO, Treasurer	P Buy	2021-08-03	2021-08-04	4,175	$15.00	$62.6K	6,898	SEC↗
Barrett Scott	Chief Medical Officer	C Conversion	2021-08-03	2021-08-04	5,996	—	$0	5,996	SEC↗
Barrett Scott	Chief Medical Officer	P Buy	2021-08-03	2021-08-04	667	$15.00	$10.0K	6,663	SEC↗
BERMAN ANN E	Director	P Buy	2021-08-03	2021-08-04	3,500	$15.00	$52.5K	3,500	SEC↗
Bookman Michael	General Counsel and Secretar	P Buy	2021-08-03	2021-08-04	1,402	$15.00	$21.0K	1,402	SEC↗
CARPENTER ROBERT J	Director	P Buy	2021-08-03	2021-08-04	325,000	$15.00	$4.88M	1,148,839	SEC↗
CARPENTER ROBERT J	Director	C Conversion	2021-08-03	2021-08-04	217,173	—	$0	823,839	SEC↗
Hall Brett Matthew	Chief Scientific Officer	C Conversion	2021-08-03	2021-08-04	5,040	—	$0	5,040	SEC↗
Hall Brett Matthew	Chief Scientific Officer	P Buy	2021-08-03	2021-08-04	1,353	$15.00	$20.3K	6,393	SEC↗
KEATING LAURIE	Director	P Buy	2021-08-03	2021-08-04	7,000	$15.00	$105.0K	7,000	SEC↗
Zeskind Benjamin J.	President and CEO	P Buy	2021-08-03	2021-08-04	2,098	$15.00	$31.5K	2,600,269	SEC↗
Zeskind Benjamin J.	President and CEO	C Conversion	2021-08-03	2021-08-04	49,099	—	$0	2,598,171	SEC↗
Feinberg Peter	Director	P Buy	2021-08-03	2021-08-04	33,333	$15.00	$500.0K	115,441	SEC↗
Feinberg Peter	Director	C Conversion	2021-08-03	2021-08-04	133,572	—	$0	257,325	SEC↗
Feinberg Peter	Director	P Buy	2021-08-03	2021-08-04	129,167	$15.00	$1.94M	386,492	SEC↗
Feinberg Peter	Director	C Conversion	2021-08-03	2021-08-04	123,155	—	$0	347,401	SEC↗
Feinberg Peter	Director	P Buy	2021-08-03	2021-08-04	129,167	$15.00	$1.94M	476,568	SEC↗
Feinberg Peter	Director	C Conversion	2021-08-03	2021-08-04	82,108	—	$0	82,108	SEC↗
Cormorant Asset Management, LP	Other	P Buy	2021-08-03	2021-08-05	550,000	$15.00	$8.25M	2,252,628	SEC↗
Cormorant Asset Management, LP	Other	C Conversion	2021-08-03	2021-08-05	1,702,628	—	$0	1,702,628	SEC↗
BERMAN ANN E	Director	A Award deriv	2021-07-29	2021-07-30	28,371	—	$0	28,371	SEC↗
Bookman Michael	General Counsel and Secretar	A Award deriv	2021-07-29	2021-07-30	101,116	—	$0	101,116	SEC↗